Thought Leadership

The experience of people suffering from irritable bowel syndrome (IBS) is often fraught with stigma, confusion, embarrassment, belittlement, and loneliness. Cerner Enviza conducted qualitative research with IBS sufferers in UK, US, Germany and China to learn more about the experiences of living with IBS.

Listen to this podcast where Sepi Varon and Lulu Lee share tips on effective communication to help advance your career.

Join us for a preview ASCO webinar where a panel of experts will share their perspectives on the potentially practice-changing results in breast cancer, novel approaches in Non-Hodgkin Lymphoma and Myelofibrosis, and a series of exciting MOAs in early-stage trials.

Recent regulatory developments and increasing domestic competition in China are now shaping development strategy for global companies

Winning in the early-stage NSCLC immunotherapy landscape and more

Strategic considerations to successfully adapt to the rapidly changing NSCLC global market following the introduction of checkpoint inhibitors in resectable disease (non-driver)